Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes

Histone deacetylase (HDAC) inhibitors are promising new epi-drugs, but the presence of both class I and class II enzymes in HDAC complexes precludes a detailed elucidation of the individual HDAC functions. By using the class II-specific HDAC inhibitor MC1568, we separated class I- and class II-depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nebbioso, Angela, Manzo, Fabio, Miceli, Marco, Conte, Mariarosaria, Manente, Lucrezia, Baldi, Alfonso, De Luca, Antonio, Rotili, Dante, Valente, Sergio, Mai, Antonello, Usiello, Alessandro, Gronemeyer, Hinrich, Altucci, Lucia
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Scientific Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693879/
https://www.ncbi.nlm.nih.gov/pubmed/19498465
http://dx.doi.org/10.1038/embor.2009.88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693879/
https://www.ncbi.nlm.nih.gov/pubmed/19498465
http://dx.doi.org/10.1038/embor.2009.88

Ejemplares similares